NASDAQ:JYNTJoint Stock Price, Forecast & News

Joint's stock was trading at $13.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, JYNT shares have increased by 3.1% and is now trading at $14.03. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint.

Joint is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Joint.

Joint Corp (NASDAQ:JYNT) posted its earnings results on Thursday, May, 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by $0.01. The company had revenue of $13.64 million for the quarter, compared to analysts' expectations of $13.03 million. Joint had a net margin of 6.20% and a return on equity of 66.44%. View Joint's earnings history.

5 brokers have issued 12-month price objectives for Joint's shares. Their forecasts range from $20.00 to $30.00. On average, they anticipate Joint's share price to reach $23.40 in the next year. This suggests a possible upside of 66.8% from the stock's current price. View analysts' price targets for Joint.

Headlines about JYNT stock have trended somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Joint earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Joint.

Joint saw a decline in short interest in June. As of June 15th, there was short interest totaling 1,730,000 shares, a decline of 7.5% from the May 31st total of 1,870,000 shares. Based on an average trading volume of 161,900 shares, the short-interest ratio is currently 10.7 days. Currently, 13.2% of the company's shares are short sold. View Joint's Current Options Chain.

Some companies that are related to Joint include Liberty Tax (TAXA), Acacia Research (ACTG), Quarterhill (QTRH), Quarterhill (QTRHF), Research Frontiers (REFR), Finjan (FNJN), Marathon Patent Group (MARA), XCel Brands (XELB), MGT Capital Investments (MGTI), Health Discovery (HDVY), Spherix (SPEX), Micro Imaging Technology (MMTC), ARC Group (ARCK), American Restaurant Partners LP Class A Partnership Units (ICTPU) and Fortel (ECGP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Ring Energy (REI), Ring Energy (REI), Walt Disney (DIS), Starbucks (SBUX), Viking Therapeutics (VKTX), Adobe (ADBE), Catalyst Pharmaceuticals (CPRX) and Corbus Pharmaceuticals (CRBP).

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $14.03.

Joint has a market capitalization of $195.58 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe.

The official website for Joint is www.thejoint.com.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]